Literature DB >> 3549562

Killing of Plasmodium falciparum by eosinophil secretory products.

L S Waters, J Taverne, P C Tai, C J Spry, G A Targett, J H Playfair.   

Abstract

The multiplication of two strains of Plasmodium falciparum in culture, as measured by [3H]hypoxanthine incorporation, was inhibited in a dose-dependent manner by granule proteins secreted by purified eosinophils obtained from patients with the hypereosinophilic syndrome. Morphological examination revealed the presence of abnormal parasites inside erythrocytes, indicating that they were killed in situ, and the later stages of the developmental cycle were found to be most susceptible to these toxic effects. A monoclonal antibody against eosinophil cationic protein partially blocked the inhibitory effect, suggesting that it was caused by more than one of the eosinophil granule proteins. Thus some of the antimalarial effects of molecules such as the tumor necrosis factor, which activates eosinophils, may be mediated through the enhanced production of eosinophil secretion products.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549562      PMCID: PMC260432          DOI: 10.1128/iai.55.4.877-881.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Concentration from continuous culture of erythrocytes infected with trophozoites and schizonts of Plasmodium falciparum.

Authors:  J B Jensen
Journal:  Am J Trop Med Hyg       Date:  1978-11       Impact factor: 2.345

2.  Protection of mice against Babesia and Plasmodium with BCG.

Authors:  I A Clark; A C Allison; F E Cox
Journal:  Nature       Date:  1976-01-29       Impact factor: 49.962

3.  Killing of the malarial parasite Plasmodium yoelii in vitro by cells of myeloid origin.

Authors:  J Taverne; H M Dockrell; J H Playfair
Journal:  Parasite Immunol       Date:  1982-03       Impact factor: 2.280

4.  Inhibition of the in vitro growth of Plasmodium falciparum by human polymorphonuclear neutrophil leucocytes.

Authors:  J Brown; M E Smalley
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

5.  Possible importance of macrophage-derived mediators in acute malaria.

Authors:  I A Clark; J L Virelizier; E A Carswell; P R Wood
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

6.  Synchronization of Plasmodium falciparum erythrocytic stages in culture.

Authors:  C Lambros; J P Vanderberg
Journal:  J Parasitol       Date:  1979-06       Impact factor: 1.276

7.  A comparison of eosinophil-activating factor (EAF) with other monokines and lymphokines.

Authors:  K J Thorne; B A Richardson; J Taverne; D J Williamson; M A Vadas; A E Butterworth
Journal:  Eur J Immunol       Date:  1986-09       Impact factor: 5.532

8.  Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis?

Authors:  I A Clark
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

9.  Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor.

Authors:  J Taverne; P Depledge; J H Playfair
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

10.  Endotoxin-induced serum factor kills malarial parasites in vitro.

Authors:  J Taverne; H M Dockrell; J H Playfair
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

View more
  18 in total

1.  Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection.

Authors:  J Zhang; K D Dyer; H F Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Complementary advantageous substitutions in the evolution of an antiviral RNase of higher primates.

Authors:  Jianzhi Zhang; Helene F Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

3.  Parasite and the Circulating Pool- Characterisation of Leukocyte Number and Morphology in Malaria.

Authors:  Reshma Gopal Kini; Jayaprakash Chandrashekhar
Journal:  J Clin Diagn Res       Date:  2016-05-01

4.  Antimicrobial Activity of Human Eosinophil Granule Proteins.

Authors:  Anu Chopra; Janendra K Batra
Journal:  Methods Mol Biol       Date:  2021

5.  Sequence variation at two eosinophil-associated ribonuclease loci in humans.

Authors:  J Zhang; H F Rosenberg
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

Review 6.  Status of malaria vaccine research.

Authors:  G A Targett
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

7.  Characterization of liver lymphomyeloid cells in mice infected with Plasmodium yoelii sporozoites.

Authors:  P Faure; M Marussig; P Goossens; F Miltgen; D Mazier
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

Review 8.  The RNase a superfamily: generation of diversity and innate host defense.

Authors:  Kimberly D Dyer; Helene F Rosenberg
Journal:  Mol Divers       Date:  2006-11       Impact factor: 2.943

9.  Killing of blood-stage Plasmodium falciparum by lipid peroxides from tumor necrosis serum.

Authors:  K A Rockett; G A Targett; J H Playfair
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

10.  Increased eosinophil activity in acute Plasmodium falciparum infection--association with cerebral malaria.

Authors:  J A Kurtzhals; C M Reimert; E Tette; S K Dunyo; K A Koram; B D Akanmori; F K Nkrumah; L Hviid
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.